Technicals:
1. Trading 12.30 in premarket as of writing, up 57.29%
2. Price broken through all of its MA's, and has established new highs in premarket
3. MACD is currently signaling bullish
Fundamentals:
https://www.marketwatch.com/story/clearside-biomedical-shares-surge-53-premarket-on-news-of-positive-trial-of-eye-disease-treatment-2018-03-05?siteid=yhoof2&yptr=yahoo
—
For the complete technical analysis on this swing trading set-up, including full price extensions and bullish/bearish targets, click here: compoundtrading.com/swing-trading-periodical-contact
1. Trading 12.30 in premarket as of writing, up 57.29%
2. Price broken through all of its MA's, and has established new highs in premarket
3. MACD is currently signaling bullish
Fundamentals:
https://www.marketwatch.com/story/clearside-biomedical-shares-surge-53-premarket-on-news-of-positive-trial-of-eye-disease-treatment-2018-03-05?siteid=yhoof2&yptr=yahoo
—
For the complete technical analysis on this swing trading set-up, including full price extensions and bullish/bearish targets, click here: compoundtrading.com/swing-trading-periodical-contact
Founder: EPIC Agentic AI | World's Best Autonomous Trading Software
dashboard.epicaitrader.com | epicaihub.io
Trading CL_F, NQ_F, BTC, ETH, SOL, TAO, SUI, XRP, Stock Basket
dashboard.epicaitrader.com | epicaihub.io
Trading CL_F, NQ_F, BTC, ETH, SOL, TAO, SUI, XRP, Stock Basket
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Founder: EPIC Agentic AI | World's Best Autonomous Trading Software
dashboard.epicaitrader.com | epicaihub.io
Trading CL_F, NQ_F, BTC, ETH, SOL, TAO, SUI, XRP, Stock Basket
dashboard.epicaitrader.com | epicaihub.io
Trading CL_F, NQ_F, BTC, ETH, SOL, TAO, SUI, XRP, Stock Basket
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.